Ancor Health Center, PA
Ancor Health Center, PA was paid $7.82M by Medicaid between Jan 2018 and Dec 2024, across 94 billing codes. Its largest line is 99469, Subsequent inpatient neonatal critical care, per day, 28 days or younger — 27% of everything it billed.
33Billing provider infoANCOR HEALTH CENTER, PA
LONGVIEW, TX 75601
LONGVIEW, TX 75601
33aNPI1992887384assigned 10/19/2006
33bProvider typeSpecialist
28Total paid$7.82M
24GClaims257,467
24DCodes billed94
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Texas
Rank by total paid#2 of 382
Median peer was paid$29K
This provider vs. median270×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 741 | $45K | |
| 2019 | 696 | $40K | |
| 2020 | 13,690 | $497K | |
| 2021 | 71,084 | $2.28M | |
| 2022 | 58,483 | $1.72M | |
| 2023 | 62,904 | $1.82M | |
| 2024incomplete | 49,869 | $1.41M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | 27% | 6,176 | 687 | $2.09M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 27,386 | 25,266 | $1.37M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 22,214 | 20,465 | $783K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.9% | 5,891 | 5,828 | $460K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.4% | 5,252 | 5,168 | $422K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.0% | 5,150 | 5,015 | $391K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.6% | 4,403 | 4,151 | $357K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.6% | 28,276 | 12,985 | $283K |
| 99468 | 3.1% | 321 | 294 | $244K | |
| 99239 | Hospital discharge day management, more than 30 minutes | 2.9% | 3,006 | 2,880 | $223K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.6% | 15,458 | 14,883 | $203K |
| 99460 | 2.4% | 2,465 | 2,402 | $186K |
82 more codes
| 99000 | 2.3% | 18,993 | $178K | |
| 90461 | <1% | 33,739 | $67K | |
| 99462 | <1% | 1,599 | $59K | |
| 99472 | Subsequent inpatient pediatric critical care, per day, 2-5 years | <1% | 145 | $58K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 678 | $39K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,897 | $39K |
| 99381 | <1% | 525 | $37K | |
| 92551 | <1% | 10,948 | $35K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,359 | $33K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 375 | $27K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 508 | $26K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,927 | $21K |
| 90619 | <1% | 1,171 | $19K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 408 | $18K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,942 | $17K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 199 | $16K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 292 | $13K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 120 | $11K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 470 | $11K |
| 83655 | <1% | 1,480 | $11K | |
| 99383 | <1% | 97 | $8K | |
| 87807 | <1% | 799 | $8K | |
| 0001A | <1% | 203 | $8K | |
| 0002A | <1% | 170 | $7K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 841 | $6K |
| 96160 | <1% | 3,533 | $5K | |
| 0072A | <1% | 139 | $4K | |
| 0071A | <1% | 148 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 368 | $4K |
| 99384 | <1% | 39 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 28 | $2K |
| 90473 | <1% | 250 | $2K | |
| 81002 | <1% | 582 | $2K | |
| 17110 | <1% | 19 | $2K | |
| 99382 | <1% | 17 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 118 | $1K |
| 87430 | <1% | 78 | $1K | |
| 17250 | <1% | 17 | $1K | |
| 99001 | <1% | 225 | $946.08 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 14 | $939.30 |
| 99356 | <1% | 28 | $533.70 | |
| 0081A | <1% | 14 | $440.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 33 | $326.52 |
| 85018 | <1% | 518 | $257.57 | |
| 90686 | <1% | 3,262 | $257.03 | |
| 96380 | <1% | 12 | $210.00 | |
| 94660 | <1% | 750 | $101.60 | |
| 90661 | <1% | 110 | $78.35 | |
| 90656 | <1% | 288 | $19.22 | |
| 90660 | <1% | 105 | $10.50 | |
| 90697 | <1% | 2,499 | $5.68 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 12 | $4.32 |
| 90677 | <1% | 1,205 | $2.40 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 29 | $0.96 |
| 90620 | <1% | 1,072 | $0.24 | |
| 90651 | <1% | 1,752 | $0.08 | |
| 90381 | <1% | 12 | $0.02 | |
| 90734 | <1% | 370 | $0.02 | |
| 90672 | <1% | 505 | $0.02 | |
| 90744 | <1% | 67 | $0.01 | |
| 90710 | <1% | 1,790 | $0.01 | |
| 90670 | <1% | 3,330 | $0.01 | |
| 90380 | <1% | 13 | $0.01 | |
| 36416 | 0% | 3,361 | $0.00 | |
| 90723 | 0% | 949 | $0.00 | |
| 90647 | 0% | 546 | $0.00 | |
| 90698 | 0% | 602 | $0.00 | |
| 91307 | 0% | 316 | $0.00 | |
| 90696 | 0% | 824 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 1,606 | $0.00 |
| 90716 | 0% | 86 | $0.00 | |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | 0% | 148 | $0.00 |
| 99173 | 0% | 11,115 | $0.00 | |
| 90633 | 0% | 2,102 | $0.00 | |
| 90707 | 0% | 112 | $0.00 | |
| 90681 | 0% | 1,897 | $0.00 | |
| 90715 | 0% | 805 | $0.00 | |
| 91300 | 0% | 465 | $0.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 156 | $0.00 |
| 99072 | 0% | 73 | $0.00 | |
| 91308 | 0% | 16 | $0.00 | |
| 90685 | 0% | 54 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOOK, EARLENE (PRACTICE MANAGER)
Parent organizationANCOR HEALTH CENTER PA
| Provider | Location | Paid |
|---|---|---|
| Ancor Health Center, PA | Longview, TX | $479K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.